FDA has issued a final guidance for industry #132, “Administrative Applications and the Phased Review Process,” which discusses the procedures a sponsor should follow to submit an administrative new animal drug application (NADA) or administrative abbreviated new animal drug application (ANADA) and the intended time frame for reviewing these administrative applications.
via What's New: Animal & Veterinary http://ift.tt/1buLmdH
No comments:
Post a Comment